Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), the leading autologous (patient's own ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company ...

BACKGROUND: A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We ...

Hemostemix's previous open-label trial in refractory angina and ischemic or dilated cardiomyopathy reported improved left-ventricular ejection fraction (LVEF), longer six-minute-walk distances, and ...

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the first patient has ...

Cardiac tamponade is most commonly caused by pericarditis, acute aortic dissection, or cardiac trauma / rupture. 1,2 Point-of-care ultrasound (POCUS) enables rapid diagnosis and t ...

A multi-institution research team led by Georgetown University Medical Center has developed and validated a model estimating ...

Ischemic cardiomyopathy was induced in wild-type C57BL/6J and TRPML1 heterozygous knockdown (TRPML1±) mice by ligating the left anterior descending coronary artery. Mice were studied at 3 weeks after ...

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed, Inc. announced the completion of a 30-day review by the Pharmaceuticals and ...

In the small first-in-human study, AB-1002 showed an encouraging safety profile and early signs of efficacy, investigators ...

A hidden atrial dysfunction may raise stroke risk in people with transthyretin amyloid cardiomyopathy (ATTR-CM); however, a ...

CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe ...